Truist Securities Reiterates CorMedix (CRMD) at Buy, Calls DefenCath NDA Resubmission a "Huge Relief"
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| CORMEDIX, Inc. (NASDAQ: CRMD) | Delayed: 7.85 -0.25 (3.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.10 | 52 Week High | $4.54 | |||
| Open | $8.01 | 52 Week Low | $1.15 | |||
| Day High | $8.11 | P/E | N/A | |||
| Day Low | $7.79 | EPS | $-0.55 | |||
| Volume | 894,540 | |||||
